Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2009-06-04

AUTHORS

Sargo Aalto, Noora M. Scheinin, Nina M. Kemppainen, Kjell Någren, Marita Kailajärvi, Mika Leinonen, Mika Scheinin, Juha O. Rinne

ABSTRACT

PurposePositron emission tomography (PET) with 11C-labelled Pittsburgh compound B ([11C]PIB) enables the quantitation of β-amyloid accumulation in the brain of patients with Alzheimer’s disease (AD). Voxel-based image analysis techniques conducted in a standard brain space provide an objective, rapid and fully automated method to analyze [11C]PIB PET data. The purpose of this study was to evaluate both region- and voxel-level reproducibility of automated and simplified [11C]PIB quantitation when using only 30 min of imaging data.MethodsSix AD patients and four healthy controls were scanned twice with an average interval of 6 weeks. To evaluate the feasibility of short scanning (convenient for AD patients), [11C]PIB uptake was quantitated using 30 min of imaging data (60 to 90 min after tracer injection) for region-to-cerebellum ratio calculations. To evaluate the reproducibility, a test-retest design was used to derive absolute variability (VAR) estimates and intraclass correlation coefficients at both region-of-interest (ROI) and voxel level.ResultsThe reproducibility both at the region level (VAR 0.9–5.5%) and at the voxel level (VAR 4.2–6.4%) was good to excellent. Based on the variability estimates obtained, power calculations indicated that 90% power to obtain statistically significant difference can be achieved using a sample size of five subjects per group when a 15% change from baseline (increase or decrease) in [11C]PIB accumulation in the frontal cortex is anticipated in one group compared to no change in another group.ConclusionOur results showed that an automated analysis method based on an efficient scanning protocol provides reproducible results for [11C]PIB uptake and appears suitable for PET studies aiming at the quantitation of amyloid accumulation in the brain of AD patients for the evaluation of progression and treatment effects. More... »

PAGES

1651-1660

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00259-009-1174-1

DOI

http://dx.doi.org/10.1007/s00259-009-1174-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1023462057

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/19495749


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Alzheimer Disease", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amyloid beta-Peptides", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aniline Compounds", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Benzothiazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Brain", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carbon Radioisotopes", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Case-Control Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cerebellum", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Image Processing, Computer-Assisted", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Magnetic Resonance Imaging", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Positron-Emission Tomography", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Radiopharmaceuticals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reproducibility of Results", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiazoles", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, University of Turku, P.O. Box 52, FI-20521, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland", 
            "Department of Psychology, \u00c5bo Akademi University, Turku, Finland", 
            "Turku PET Centre, University of Turku, P.O. Box 52, FI-20521, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Aalto", 
        "givenName": "Sargo", 
        "id": "sg:person.01116710536.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116710536.84"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scheinin", 
        "givenName": "Noora M.", 
        "id": "sg:person.01142154401.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142154401.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Neurology, Turku University Hospital, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.410552.7", 
          "name": [
            "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland", 
            "Department of Neurology, Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kemppainen", 
        "givenName": "Nina M.", 
        "id": "sg:person.01122137640.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122137640.52"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "N\u00e5gren", 
        "givenName": "Kjell", 
        "id": "sg:person.01247470501.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247470501.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku Imanet, GE Healthcare, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Pharmacology and Clinical Research Services Turku (CRST), University of Turku, Turku, Finland", 
            "Turku Imanet, GE Healthcare, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kailaj\u00e4rvi", 
        "givenName": "Marita", 
        "id": "sg:person.01023301313.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023301313.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "4-Pharma Ltd, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "4-Pharma Ltd, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Leinonen", 
        "givenName": "Mika", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pharmacology and Clinical Research Services Turku (CRST), University of Turku, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.1374.1", 
          "name": [
            "Department of Pharmacology and Clinical Research Services Turku (CRST), University of Turku, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Scheinin", 
        "givenName": "Mika", 
        "id": "sg:person.0726067730.61", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726067730.61"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland", 
          "id": "http://www.grid.ac/institutes/grid.470895.7", 
          "name": [
            "Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rinne", 
        "givenName": "Juha O.", 
        "id": "sg:person.012653127617.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012653127617.40"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1471-2377-9-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030131334", 
          "https://doi.org/10.1186/1471-2377-9-2"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-06-04", 
    "datePublishedReg": "2009-06-04", 
    "description": "PurposePositron emission tomography (PET) with 11C-labelled Pittsburgh compound B ([11C]PIB) enables the quantitation of \u03b2-amyloid accumulation in the brain of patients with Alzheimer\u2019s disease (AD). Voxel-based image analysis techniques conducted in a standard brain space provide an objective, rapid and fully automated method to analyze [11C]PIB PET data. The purpose of this study was to evaluate both region- and voxel-level reproducibility of automated and simplified [11C]PIB quantitation when using only 30\u00a0min of imaging data.MethodsSix AD patients and four healthy controls were scanned twice with an average interval of 6\u00a0weeks. To evaluate the feasibility of short scanning (convenient for AD patients), [11C]PIB uptake was quantitated using 30\u00a0min of imaging data (60 to 90\u00a0min after tracer injection) for region-to-cerebellum ratio calculations. To evaluate the reproducibility, a test-retest design was used to derive absolute variability (VAR) estimates and intraclass correlation coefficients at both region-of-interest (ROI) and voxel level.ResultsThe reproducibility both at the region level (VAR 0.9\u20135.5%) and at the voxel level (VAR 4.2\u20136.4%) was good to excellent. Based on the variability estimates obtained, power calculations indicated that 90% power to obtain statistically significant difference can be achieved using a sample size of five subjects per group when a 15% change from baseline (increase or decrease) in [11C]PIB accumulation in the frontal cortex is anticipated in one group compared to no change in another group.ConclusionOur results showed that an automated analysis method based on an efficient scanning protocol provides reproducible results for [11C]PIB uptake and appears suitable for PET studies aiming at the quantitation of amyloid accumulation in the brain of AD patients for the evaluation of progression and treatment effects.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s00259-009-1174-1", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1297401", 
        "issn": [
          "1619-7070", 
          "1619-7089"
        ], 
        "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "10", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "keywords": [
      "PurposePositron emission tomography", 
      "amyloid accumulation", 
      "AD patients", 
      "Alzheimer's disease", 
      "brains of patients", 
      "Pittsburgh compound B", 
      "evaluation of progression", 
      "PET amyloid ligand", 
      "voxel-based analysis", 
      "standard brain space", 
      "healthy controls", 
      "frontal cortex", 
      "test-retest design", 
      "voxel level", 
      "emission tomography", 
      "PET studies", 
      "patients", 
      "scanning protocol", 
      "compound B", 
      "average interval", 
      "ConclusionOur results", 
      "treatment effects", 
      "significant differences", 
      "amyloid ligands", 
      "brain space", 
      "disease", 
      "brain", 
      "group", 
      "PET data", 
      "power calculation", 
      "sample size", 
      "absolute variability", 
      "uptake", 
      "min", 
      "levels", 
      "cortex", 
      "baseline", 
      "progression", 
      "weeks", 
      "tomography", 
      "accumulation", 
      "short scanning", 
      "correlation coefficient", 
      "quantitation", 
      "study", 
      "subjects", 
      "variability estimates", 
      "data", 
      "changes", 
      "reproducibility", 
      "reproducible results", 
      "ratio calculations", 
      "intervals", 
      "differences", 
      "control", 
      "evaluation", 
      "protocol", 
      "scanning", 
      "voxels", 
      "variability", 
      "effect", 
      "results", 
      "region", 
      "purpose", 
      "feasibility", 
      "region level", 
      "method", 
      "ligands", 
      "image analysis techniques", 
      "analysis", 
      "size", 
      "technique", 
      "estimates", 
      "interest", 
      "design", 
      "analysis techniques", 
      "analysis method", 
      "coefficient", 
      "space", 
      "scanning data", 
      "power", 
      "calculations"
    ], 
    "name": "Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data", 
    "pagination": "1651-1660", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1023462057"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00259-009-1174-1"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "19495749"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00259-009-1174-1", 
      "https://app.dimensions.ai/details/publication/pub.1023462057"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:25", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_481.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s00259-009-1174-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1174-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1174-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1174-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-009-1174-1'


 

This table displays all metadata directly associated to this object as RDF triples.

288 TRIPLES      22 PREDICATES      128 URIs      119 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00259-009-1174-1 schema:about N03cc4082a841408a96b9953f6ccc4ee9
2 N083dc2398fb04c39a786828af5c4ca59
3 N44368cb38858449787973d1985434ed6
4 N49cb57e494af47688a743e8bf5cb50bc
5 N5a64d181ba23419aa28d10081e5c3b57
6 N5c8e9b233aa64d10908cf1c7efda575e
7 N62680a7795234245a263e16913811baa
8 N651c9af32f254b1399feb267640315b0
9 N76e6473c078f4a79b1e54a2a62c385f1
10 N78f92143bf504bc3a38cbfb125911713
11 N7fec2fe398ef48e1bbe73fe3d14a74a6
12 N83f99a81df7445e09406d44be30e38e9
13 N8c61575dda12487eb98ca48ec135f79d
14 N93d27c68cdc5408f965b5e72ef392beb
15 Naffa124d22594f2a8c1ea78d67ace77f
16 Nb53bf2cc5236465b9f524ea5decef8d1
17 Ndbdb896b6ac94fe484ae49b10ae4d6db
18 Ne3037df3aafa4e358192f76ff9349fc6
19 Ne99762964e38478580ff70f394dd8956
20 anzsrc-for:11
21 anzsrc-for:1109
22 schema:author N3f388c71cebd438294fa72780ac42048
23 schema:citation sg:pub.10.1186/1471-2377-9-2
24 schema:datePublished 2009-06-04
25 schema:datePublishedReg 2009-06-04
26 schema:description PurposePositron emission tomography (PET) with 11C-labelled Pittsburgh compound B ([11C]PIB) enables the quantitation of β-amyloid accumulation in the brain of patients with Alzheimer’s disease (AD). Voxel-based image analysis techniques conducted in a standard brain space provide an objective, rapid and fully automated method to analyze [11C]PIB PET data. The purpose of this study was to evaluate both region- and voxel-level reproducibility of automated and simplified [11C]PIB quantitation when using only 30 min of imaging data.MethodsSix AD patients and four healthy controls were scanned twice with an average interval of 6 weeks. To evaluate the feasibility of short scanning (convenient for AD patients), [11C]PIB uptake was quantitated using 30 min of imaging data (60 to 90 min after tracer injection) for region-to-cerebellum ratio calculations. To evaluate the reproducibility, a test-retest design was used to derive absolute variability (VAR) estimates and intraclass correlation coefficients at both region-of-interest (ROI) and voxel level.ResultsThe reproducibility both at the region level (VAR 0.9–5.5%) and at the voxel level (VAR 4.2–6.4%) was good to excellent. Based on the variability estimates obtained, power calculations indicated that 90% power to obtain statistically significant difference can be achieved using a sample size of five subjects per group when a 15% change from baseline (increase or decrease) in [11C]PIB accumulation in the frontal cortex is anticipated in one group compared to no change in another group.ConclusionOur results showed that an automated analysis method based on an efficient scanning protocol provides reproducible results for [11C]PIB uptake and appears suitable for PET studies aiming at the quantitation of amyloid accumulation in the brain of AD patients for the evaluation of progression and treatment effects.
27 schema:genre article
28 schema:inLanguage en
29 schema:isAccessibleForFree false
30 schema:isPartOf N049dbe02640b42cdafa5398d217cdb0c
31 Nbd7aee62e3604934bd24ce185b90b218
32 sg:journal.1297401
33 schema:keywords AD patients
34 Alzheimer's disease
35 ConclusionOur results
36 PET amyloid ligand
37 PET data
38 PET studies
39 Pittsburgh compound B
40 PurposePositron emission tomography
41 absolute variability
42 accumulation
43 amyloid accumulation
44 amyloid ligands
45 analysis
46 analysis method
47 analysis techniques
48 average interval
49 baseline
50 brain
51 brain space
52 brains of patients
53 calculations
54 changes
55 coefficient
56 compound B
57 control
58 correlation coefficient
59 cortex
60 data
61 design
62 differences
63 disease
64 effect
65 emission tomography
66 estimates
67 evaluation
68 evaluation of progression
69 feasibility
70 frontal cortex
71 group
72 healthy controls
73 image analysis techniques
74 interest
75 intervals
76 levels
77 ligands
78 method
79 min
80 patients
81 power
82 power calculation
83 progression
84 protocol
85 purpose
86 quantitation
87 ratio calculations
88 region
89 region level
90 reproducibility
91 reproducible results
92 results
93 sample size
94 scanning
95 scanning data
96 scanning protocol
97 short scanning
98 significant differences
99 size
100 space
101 standard brain space
102 study
103 subjects
104 technique
105 test-retest design
106 tomography
107 treatment effects
108 uptake
109 variability
110 variability estimates
111 voxel level
112 voxel-based analysis
113 voxels
114 weeks
115 schema:name Reproducibility of automated simplified voxel-based analysis of PET amyloid ligand [11C]PIB uptake using 30-min scanning data
116 schema:pagination 1651-1660
117 schema:productId N9f62e80e61664e37ae1c9fbca9f03198
118 Nb60583f135cb4470aed3dfe0866d4ecc
119 Nf8666e719a574091aebb1716661dd72a
120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023462057
121 https://doi.org/10.1007/s00259-009-1174-1
122 schema:sdDatePublished 2022-05-20T07:25
123 schema:sdLicense https://scigraph.springernature.com/explorer/license/
124 schema:sdPublisher N3497bda4987b4901994412b0ef3d9afd
125 schema:url https://doi.org/10.1007/s00259-009-1174-1
126 sgo:license sg:explorer/license/
127 sgo:sdDataset articles
128 rdf:type schema:ScholarlyArticle
129 N03cc4082a841408a96b9953f6ccc4ee9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Image Processing, Computer-Assisted
131 rdf:type schema:DefinedTerm
132 N049dbe02640b42cdafa5398d217cdb0c schema:volumeNumber 36
133 rdf:type schema:PublicationVolume
134 N083dc2398fb04c39a786828af5c4ca59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Female
136 rdf:type schema:DefinedTerm
137 N30c19c4763bd42af8cf28e40419816f1 rdf:first sg:person.01247470501.42
138 rdf:rest N9b73cefce7354423ba9bd01e69e1ddac
139 N3497bda4987b4901994412b0ef3d9afd schema:name Springer Nature - SN SciGraph project
140 rdf:type schema:Organization
141 N35d701a9e3c541c7b6b7a0cdbe763a5a rdf:first sg:person.01142154401.21
142 rdf:rest Nc766af1885824e33aba1eee309a60015
143 N35dcbe677fa64655881af31e59f11f99 schema:affiliation grid-institutes:None
144 schema:familyName Leinonen
145 schema:givenName Mika
146 rdf:type schema:Person
147 N3f388c71cebd438294fa72780ac42048 rdf:first sg:person.01116710536.84
148 rdf:rest N35d701a9e3c541c7b6b7a0cdbe763a5a
149 N44368cb38858449787973d1985434ed6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Reproducibility of Results
151 rdf:type schema:DefinedTerm
152 N49cb57e494af47688a743e8bf5cb50bc schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Carbon Radioisotopes
154 rdf:type schema:DefinedTerm
155 N5a64d181ba23419aa28d10081e5c3b57 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
156 schema:name Case-Control Studies
157 rdf:type schema:DefinedTerm
158 N5c8e9b233aa64d10908cf1c7efda575e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
159 schema:name Cerebellum
160 rdf:type schema:DefinedTerm
161 N62680a7795234245a263e16913811baa schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Magnetic Resonance Imaging
163 rdf:type schema:DefinedTerm
164 N651c9af32f254b1399feb267640315b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
165 schema:name Alzheimer Disease
166 rdf:type schema:DefinedTerm
167 N6a33f6ab0c7041c3adcd3477520577f8 rdf:first sg:person.012653127617.40
168 rdf:rest rdf:nil
169 N76e6473c078f4a79b1e54a2a62c385f1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
170 schema:name Brain
171 rdf:type schema:DefinedTerm
172 N78f92143bf504bc3a38cbfb125911713 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Aniline Compounds
174 rdf:type schema:DefinedTerm
175 N7fec2fe398ef48e1bbe73fe3d14a74a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Positron-Emission Tomography
177 rdf:type schema:DefinedTerm
178 N83f99a81df7445e09406d44be30e38e9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Aged
180 rdf:type schema:DefinedTerm
181 N8c61575dda12487eb98ca48ec135f79d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Thiazoles
183 rdf:type schema:DefinedTerm
184 N8f6f93d8b112423faf92c85c51e30ca0 rdf:first N35dcbe677fa64655881af31e59f11f99
185 rdf:rest Ncd7aa32c349345c2a7419c802deeffaf
186 N93d27c68cdc5408f965b5e72ef392beb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
187 schema:name Middle Aged
188 rdf:type schema:DefinedTerm
189 N9b73cefce7354423ba9bd01e69e1ddac rdf:first sg:person.01023301313.48
190 rdf:rest N8f6f93d8b112423faf92c85c51e30ca0
191 N9f62e80e61664e37ae1c9fbca9f03198 schema:name pubmed_id
192 schema:value 19495749
193 rdf:type schema:PropertyValue
194 Naffa124d22594f2a8c1ea78d67ace77f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
195 schema:name Radiopharmaceuticals
196 rdf:type schema:DefinedTerm
197 Nb53bf2cc5236465b9f524ea5decef8d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
198 schema:name Humans
199 rdf:type schema:DefinedTerm
200 Nb60583f135cb4470aed3dfe0866d4ecc schema:name dimensions_id
201 schema:value pub.1023462057
202 rdf:type schema:PropertyValue
203 Nbd7aee62e3604934bd24ce185b90b218 schema:issueNumber 10
204 rdf:type schema:PublicationIssue
205 Nc766af1885824e33aba1eee309a60015 rdf:first sg:person.01122137640.52
206 rdf:rest N30c19c4763bd42af8cf28e40419816f1
207 Ncd7aa32c349345c2a7419c802deeffaf rdf:first sg:person.0726067730.61
208 rdf:rest N6a33f6ab0c7041c3adcd3477520577f8
209 Ndbdb896b6ac94fe484ae49b10ae4d6db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
210 schema:name Benzothiazoles
211 rdf:type schema:DefinedTerm
212 Ne3037df3aafa4e358192f76ff9349fc6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Amyloid beta-Peptides
214 rdf:type schema:DefinedTerm
215 Ne99762964e38478580ff70f394dd8956 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
216 schema:name Male
217 rdf:type schema:DefinedTerm
218 Nf8666e719a574091aebb1716661dd72a schema:name doi
219 schema:value 10.1007/s00259-009-1174-1
220 rdf:type schema:PropertyValue
221 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
222 schema:name Medical and Health Sciences
223 rdf:type schema:DefinedTerm
224 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
225 schema:name Neurosciences
226 rdf:type schema:DefinedTerm
227 sg:journal.1297401 schema:issn 1619-7070
228 1619-7089
229 schema:name European Journal of Nuclear Medicine and Molecular Imaging
230 schema:publisher Springer Nature
231 rdf:type schema:Periodical
232 sg:person.01023301313.48 schema:affiliation grid-institutes:None
233 schema:familyName Kailajärvi
234 schema:givenName Marita
235 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01023301313.48
236 rdf:type schema:Person
237 sg:person.01116710536.84 schema:affiliation grid-institutes:grid.470895.7
238 schema:familyName Aalto
239 schema:givenName Sargo
240 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116710536.84
241 rdf:type schema:Person
242 sg:person.01122137640.52 schema:affiliation grid-institutes:grid.410552.7
243 schema:familyName Kemppainen
244 schema:givenName Nina M.
245 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122137640.52
246 rdf:type schema:Person
247 sg:person.01142154401.21 schema:affiliation grid-institutes:grid.470895.7
248 schema:familyName Scheinin
249 schema:givenName Noora M.
250 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142154401.21
251 rdf:type schema:Person
252 sg:person.01247470501.42 schema:affiliation grid-institutes:grid.470895.7
253 schema:familyName Någren
254 schema:givenName Kjell
255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01247470501.42
256 rdf:type schema:Person
257 sg:person.012653127617.40 schema:affiliation grid-institutes:grid.470895.7
258 schema:familyName Rinne
259 schema:givenName Juha O.
260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012653127617.40
261 rdf:type schema:Person
262 sg:person.0726067730.61 schema:affiliation grid-institutes:grid.1374.1
263 schema:familyName Scheinin
264 schema:givenName Mika
265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0726067730.61
266 rdf:type schema:Person
267 sg:pub.10.1186/1471-2377-9-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030131334
268 https://doi.org/10.1186/1471-2377-9-2
269 rdf:type schema:CreativeWork
270 grid-institutes:None schema:alternateName 4-Pharma Ltd, Turku, Finland
271 Turku Imanet, GE Healthcare, Turku, Finland
272 schema:name 4-Pharma Ltd, Turku, Finland
273 Department of Pharmacology and Clinical Research Services Turku (CRST), University of Turku, Turku, Finland
274 Turku Imanet, GE Healthcare, Turku, Finland
275 rdf:type schema:Organization
276 grid-institutes:grid.1374.1 schema:alternateName Department of Pharmacology and Clinical Research Services Turku (CRST), University of Turku, Turku, Finland
277 schema:name Department of Pharmacology and Clinical Research Services Turku (CRST), University of Turku, Turku, Finland
278 rdf:type schema:Organization
279 grid-institutes:grid.410552.7 schema:alternateName Department of Neurology, Turku University Hospital, Turku, Finland
280 schema:name Department of Neurology, Turku University Hospital, Turku, Finland
281 Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland
282 rdf:type schema:Organization
283 grid-institutes:grid.470895.7 schema:alternateName Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland
284 Turku PET Centre, University of Turku, P.O. Box 52, FI-20521, Turku, Finland
285 schema:name Department of Psychology, Åbo Akademi University, Turku, Finland
286 Turku PET Centre, University of Turku and Turku University Hospital, Turku, Finland
287 Turku PET Centre, University of Turku, P.O. Box 52, FI-20521, Turku, Finland
288 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...